Abingworth is a renowned brand that has been investing in life science companies since the early days of the biotechnology industry. With an impressive portfolio of over 180 companies, Abingworth's experience and expertise are unrivaled. The brand's success lies in its transatlantic operation, with offices in key biotech hubs in the US and Europe.

By being physically present in these locations, Abingworth can engage in face-to-face discussions and informal get-togethers, fostering better relationships with the entrepreneurs they support. Moreover, these offices allow Abingworth to tap into deep talent pools and scientific networks. The brand has raised 14 funds dedicated to life sciences and healthcare, including Abingworth Bioventures 8 and Abingworth Clinical Co-Development Fund 2, which raised $466 million and $583 million respectively.

These funds invest in private and public companies across various strategic areas, such as seed and early stage, development stage, and clinical co-development. Abingworth is a leader in the industry, committed to shaping the future of life sciences